Search

everythinglearnresearchcommunity

for

Search:↓

New methods are being developed to improve drug delivery to the brain.

Isotretinoin was not effective in treating facial lichen planopilaris.

SLE can cause unusual gastrointestinal symptoms, and immunosuppressive therapy can be effective.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Certain steroids in the brain affect mood and symptoms of depression, and treatments targeting these steroids show promise for improving these symptoms.

New markers can detect tumors, aid drug delivery, and treat cancer effectively and safely.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

Alopecia can often be managed effectively with various treatments, but early diagnosis is crucial for preventing permanent hair loss.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

Scientists now better understand the genetics of hypohidrotic ectodermal dysplasia, leading to more accurate diagnoses and potential new treatments.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

The document explains various skin conditions and their treatments.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

New cytokine-targeted therapies show promise for treating alopecia areata.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

Modern lifestyles, including poor diet, stress, and long-term use of certain medications, hinder the body's ability to heal from inflammation, leading to chronic diseases.

Immune cells affect hair growth and could lead to new hair loss treatments.